| Market Cap | ₹1,69,385Cr |
| ROE | 16.12% |
| P/E Ratio(TTM) | 68.16 |
| EPS(TTM) | 93.61 |
| P/B Ratio | 10.99 |
| Dividend Yield | 0.47% |
| Industry P/E | 33.18 |
| Book Value | 580.60 |
| Debt to Equity | 0.01 |
| Face Value | 2 |
| Parent Organisation | Divi's Laboratories Limited |
| Managing Director | Dr. Kiran S. Divi |
| Founded | 1990 |
| NSE Symbol | DIVISLAB |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Neuland Laboratories | NA (0.00%) | 84.50 | ||
| Jubilant Pharmova | NA (0.00%) | 35.37 | ||
| Acutaas Chemicals | NA (0.00%) | 59.16 | ||
| Gujarat Themis Biosyn | NA (0.00%) | 87.97 |